Upon completion of the study, the company plans to submit the OTTAVA system for De Novo authorization in the U.S.

Johnson & Johnson MedTech (NYSE: JNJ) announced today that investigators completed the first cases with its Ottava surgical ...

Intuitive Surgical leads in robotic surgery, but rising competition and high valuations urge caution. See why we are neutral ...

The global surgical robots market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by ...

Johnson & Johnson MedTech, a global leader in surgical technologies and solutions, today announced completion of the first cases in the clinical trial for the OTTAVA™ Robotic Surgical System. The ...

Johnson & Johnson MedTech reported that it has completed the first U.S. clinical cases of its Ottava surgical robot, with a ...

Upon completion of the study, the company plans to submit the OTTAVA system for De Novo authorization in the United States.

Johnson & Johnson plans to seek a U.S. indication for multiple general surgery procedures, including gastric bypass, which ...